Collaborators of CKD-EPI Aim 1

Study Name/Name of Institution Collaborators
African American Study of Kidney Disease and Hypertension (AASK) Gabriel Contreras, MD MPH, Julia B. Lewis, MD
Baylor University Medical Cente Goran B. Klintmalm, MD PhD
Captopril in Diabetic Nephropathy Study (CSG) Roger A. Rodby, MD, Richard D. Rohde, BS
Chronic Renal Insufficiency Cohort (CRIC) Harold I. Feldman, MD MSCE, Lawrence J. Appel, MD MPH, Jing Chen, MD MS, Alan S. Go, MD,Lee Hamm, MD,Chi-yuan Hsu, MD,J ames P. Lash, MD, Akinlolu O. Ojo, MD, MahboobRahman, MD,Raymond R. Townsend, MD,Matthew R. Weir, MD,Jackson T. Wright, MD
Cleveland Clinic Foundation (CCF) Phillip Hall, MD, Emilio Poggio, MD
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Vicente Torres, MD PhD
Dallas Nephrology Associates (DNA) Larry Melton, MD PhD FACP, Ruben Velez, MD
Diabetes Control and Complications Trial (DCCT) Saul Genuth, MD, Michael W. Steffes, MD PhD
Diabetic Renal Disease Study Group (DRDS): Robert G. Nelson, MD PhD
Groningen Renal Hemodynamic Cohort Study Group (GRECO) Gerjan Navis, MD PhD
International Diabetic Nephropathy Study Group (IDNSG) and the Renin-Angiontensin System Study(RASS) Michael Mauer, MD
Departments of Clinical Chemistry and Nephrology, University Hospital, Lund, Sweden Anders Grubb, MD PhD, Omran Bakoush, MD PhD
Mayo Clinic Andrew D. Rule, MD MS, Timothy Larson, MD, Fernando Cosio, MD
Modification of Diet in Renal Disease (MDRD) Study Gerald Beck, PhD
Nephro Test Cohort Jerome Rossert, MD PhD, Marc Froissart, MD PhD
Steno Diabetes Center Hans-Henrik Parving, MD PhD, Peter Rossing, MD DMSc

Collaborators of CKD-EPI Aim 3

Study Name/Name of Institution Collaborators
African American Study of Kidney Disease and Hypertension (AASK) Tom Greene, PhD
University of Texas Southwestern Medical Center Robert Toto, MD
University Hospital Groningen GG van Essen MD
The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group GuiseppeMaschio, MD
University of Copenhagen Anne Lise Kamper
Brigham and Women’s Hospital Barry M. Brenner
The Royal Melbourne Hospital,Victoria, Australia Benno U. Ihle MBBS, FRACP, FJFICM; Priscilla S. Kincaid-Smith MD, DSc
University Hospital, Strasbourg, France Thierry P. Hannedouche, MD
Hong Kong Study Using Valsartan in IgA Nephropathy (HKVIN) Philip Kam-Tao Li, MD, FRCP, FACP
Nanfang Hospital, Southern Medical University Fan Fan Hou, MD, PhD
Hospital 12 de Octubre, Madrid, Spain Manuel Praga, MD
Captopril in Diabetic Nephropathy Study (CSG) Roger A. Rodby, MD, Richard D. Rohde, BS
Reduction of Endpoints in NIDDM with theAngiotensin II Antagonist Losartan (RENAAL) Dick De Zeeuw, MD, PhD; Barry M. Brenner, MD; William Keane, MD
Ramipril Efficacy In Nephropathy (REIN) Giuseppe Remuzzi, MD, FRCP, Piero Ruggenenti MD
Irbesartan in Diabetic Nephropathy Trial (IDNT) Ed Lewis, MD; Lawrence G. Hunsicker, MD
Appropriate Blood Pressure Control in Diabetes (ABCD) Robert W. Schrier, MD, Raymond O. Estacio, MD
Ospedale M. Malpighi, Bologna, Italy Pietro Zucchelli, MD
Modification of Diet in Renal Disease (MDRD) Study A and B Gerald Beck, PhD
Ramipril Efficacy In Nephropathy (REIN-2) Giuseppe Remuzzi, MD, FRCP; Piero Ruggenenti MD
University Hospital Gasthuisberg, Leuven, Belgium Bart Maes, MD, PhD
Mayo Clinic, Rochester, Minnesota, USA James Donadio, MD; Fernando Fervenza, MD
New York Presbyterian Hospital, Columbia University, New York, USA Gerald B. Appel, MD; Gershon Frisch, MD
Euro Lupus Nephritis Trial (ELNT) Frédéric A. Houssiau, MD, PhD
University of Hong Kong, Queen Mary Hospital Tak-Mao Chan MD
Lupus Nephritis Collaborative Study (LNCS) Edmund Lewis, MD; John M. Lachin, ScD
University of Toronto Daniel C. Cattran, MD, FRCPC
IRCCS Istituto Humanitas, Milan, Italy Claudio Ponticelli, MD; PatriziaPasserini, MD; Gabriella Moroni, MD; Giuseppe Montogrino, MD
GrupoEspañol de estudio de la Nefropatía Membranosa_ Manuel Praga, MD